46. Farese JP, Milner R, Thompson MS, et al. Stereotactic radiosurgery for the treatment of osteosarcomas involving the distal
portions of the limbs in dogs. J Am Vet Med Assoc 2004;225:1567-1572.
47. Bova FJ, Buatti JM, Friedman WA, et al. The University of Florida frameless high-precision stereotactic radiotherapy system.
Int J Radiat Oncol Biol Phys 1997;38:875-882.
48. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-694.
49. Shapiro W, Fossum TW, Kitchell BE, et al. Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 1988;192:507-511.
50. Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 1991;5:205-210.
51. Berg J, Weinstein MJ, Springfield DS, et al. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 1995;206:1555-1560.
52. Berg J, Gebhardt MC, Rand WM. Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 1997;79:1343-1350.
53. Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of
cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc 1992;200:531-533.
54. Mauldin GN, Matus RE, Withrow SJ, et al. Canine osteosarcoma: Treatment by amputation versus amputation and adjuvant chemotherapy
using doxorubicin and cisplatin. J Vet Intern Med 1988;2:177-180.
55. Chun R, Garrett LD, Henry C, et al. Cisplatin and doxorubicin combination for the treatment of canine osteosarcoma, in Proceedings. 21st Annu Vet Cancer Soc Conf 2001;7.
56. Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991
to 1993). J Vet Intern Med 1996;10:76-81.
57. Bailey D, Erb H, Williams L, et al. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular
osteosarcoma in the dog. J Vet Intern Med 2003;17:199-205.
58. Kent MS, Strom A, London CA, et al. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing
surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med 2004;18:540-544.
59. Ogilvie GK, Straw RC, Powers BE, et al. Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis
protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989). J Am Vet Med Assoc 1991;199:613-616.
60. Chun R, Kurzman ID, Couto CG, et al. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma:
A pilot study. J Vet Intern Med 2000;14:495-498.
61. Straw RC, Withrow SJ, Douple EB, et al. Effects of cis-diamminedichloroplatinum II released from D,L-polylactic acid implanted
adjacent to cortical allografts in dogs. J Orthop Res 1994;12:871-877.
62. MacEwen EG, Kurzman ID, Rosenthal RC, et al. Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated
muramyl tripeptide. J Natl Cancer Inst 1989;81:935-938.
63. Ogilvie GK, Straw RC, Jameson VJ, et al. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma
metastases in dogs: 45 cases (1987-1991). J Am Vet Med Assoc 1993;202:304-306.
64. Ross JR, Saunders Y, Edmonds PM, et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic
cancer. BMJ 2003;327(7413):469.
65. Tomlin JL, Sturgeon C, Pead MJ, et al. Use of the bisphosphonate drug alendronate for palliative management of osteosarcomas
in two dogs. Vet Rec 2000;147:129-132.
66. Farese JP, Ashton J, Milner R, et al. The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells
in vitro. In Vitro Cell Dev Biol Anim 2004;40:113-117.
67. Poirier VJ, Huelsmeyer MK, Kurzman ID, et al. The bisphosphonates alendronate and zoledronate are inhibitors of canine and
human osteosarcoma cell growth in vitro. Vet Compar Oncol 2003;1:207-215.
68. Ashton J, Farese JP, Milner RJ, et al. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma
cells from dogs. Am J Vet Res 2005:in press.
|
Featuring Information from:
